NCT07018349Not yet recruiting
Low Dose Oral Minoxdil in Androgenic Alopecia
In the register
The register attaches this trial to Minoxidil (low-dose oral), currently at “Marketed, off-label” in the register. The programme's phase is checked by hand; the trial's is declared by its sponsor.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Jinnah Postgraduate Medical Centre
- Participants (registry)
- 76
- Start
- June 2025 (planned)
- Primary completion
- September 2025
- Study completion
- October 2025
- Last registry update
- June 2025
- Countries
- Pakistan
Conditions studied: Androgenetic Alopecia (AGA)
Interventions: 2.5% Oral minoxidil, 1% Oral Minoxidil
Other trials of Minoxidil (low-dose oral)
A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.